The research of PET/CT imaging with 18F-P137 in nasopharyngeal carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200061909

Enrollment

Unknown

Registered

2022-07-10

Start date

2022-07-11

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-70 years; 2. Patients diagnosed with nasopharyngeal carcinoma by clinical and routine imaging; 3. Normal liver and kidney function; 4. Able to understand and voluntarily sign the informed consent form, with good compliance.

Exclusion criteria

Exclusion criteria: 1. Pregnant, pregnant or lactating women; 2. Suffering from claustrophobia or other mental illnesses; 3. Other investigators believe that they are not suitable for participating in the trial.

Design outcomes

Primary

Measure	Time frame
standard uptake value;	—

Countries

China

Contacts

Public ContactKun Wang

CAS Key Laboratory of Molecular Imaging

kun.wang@ia.ac.cn+86 18612965656

Outcome results